
BillionToOne is a precision diagnostics company dedicated to transforming healthcare through its proprietary Quantitative Counting Templates (QCTs™) technology. This innovative platform enables the direct measurement of disease-causing DNA fragments at the single base-pair level, significantly enhancing the accuracy and efficiency of molecular diagnostics. By quantifying these minute variations using cell-free DNA, BillionToOne aims to revolutionize prenatal screening, liquid biopsy, and other diagnostic applications.